Literature DB >> 24438983

Dermatomyositis associated with capecitabine in the setting of malignancy.

Frank W Chen1, Xiaolong Zhou1, Barbara M Egbert2, Susan M Swetter3, Kavita Y Sarin4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24438983     DOI： 10.1016/j.jaad.2013.10.025

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  3 in total

1.  Acute worsening of dermatomyositis after initiation of PARP inhibitor therapy in two women with advanced ovarian malignancy.

Authors:  Stephen M Graves; Floor J Backes
Journal:  Gynecol Oncol Rep       Date:  2021-10-02

2.  Severe myositis of the hip flexors after pre-operative chemoradiation therapy for locally advanced rectal cancer: case report.

Authors:  Matthew M Florczynski; Michael S Sanatani; Lauren Mai; Barbara Fisher; Dwight E Moulin; Jeffrey Cao; Alexander V Louie; Janet E Pope; Eric Leung
Journal:  BMC Cancer       Date:  2016-03-22       Impact factor: 4.430

3.  Occurrence of Dermatomyositis Immediately after Mastectomy Subsequent to Severe Chemotherapeutic Drug Eruption.

Authors:  Yuki Otsuka; Haruki Watanabe; Yuzuki Kano; Noriko Tatebe; Katsue Sunahori-Watanabe; Tomoko Kawabata; Ken-Ei Sada; Jun Wada
Journal:  Intern Med       Date:  2017-12-15       Impact factor: 1.271
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.